Clinical Trial Update: Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating D-cycloserine as an adjunct to cognitive behavioral therapy for schizophrenia has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-09-05